undamentalytics Newsletter
Sign in

Liquidia Corp income statement

In fiscal 2025, Liquidia Corp reported revenue of $158m, up 1031.2% on the year before, operating income of −$51.4m (a -32.5% margin) and net income of −$68.9m, or −$0.80 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue8113161714158451
Cost of revenue—03336——
Gross profit—11013158——
Research and development4032211943483956
Selling, general and administrative————4582157193
General and administrative14272332————
Operating income−47−59−34−39−73−121−51169
Interest expense11126152427
Income tax0000000—
Net income−48−60−35−41−79−128−69139
Diluted EPS−$2.57−$1.76−$0.70−$0.67−$1.21−$1.63−$0.80$1.47
Diluted shares (average)18m34m50m61m65m79m86m94m
EBITDA−44−56−28−35−71−119−50170

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: INVA vs LQDAIRWD vs LQDAALVO vs LQDA

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Liquidia Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Liquidia Corp.